Purchase Order HT940626PE004
- Not listed
- The Defense Health Agency awarded a $39,282.35 firm fixed-price purchase order to Haemonetics Corporation for hemostasis supplies. The award, issued on August 8, 2025, with an ultimate completion date of August 8, 2025, represents a straightforward procurement with no set-aside designation, indicating open and competitive bidding. Performance will take place in Bethesda, Maryland. Haemonetics, a Boston-based medical technology leader, specializes in blood and plasma management products and is...
- The Defense Health Agency awarded a $69,732 firm fixed-price purchase order to Haemonetics Corporation for maintenance, repair, and rebuild services on medical equipment at a San Diego, California facility. The contract, which became effective October 1, 2024, will run through September 30, 2027, and was awarded on a competitive basis with no set-aside designation. Haemonetics Corporation, headquartered in Boston, Massachusetts, is a leading provider of blood and plasma management products and...
- The federal contract award HT940623P0100, valued at $91,029.00, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the provision of implementation services. This is a firm-fixed-price purchase order contract with no set-aside designation, indicating Haemonetics' competitiveness as a large, established provider of specialized medical equipment and services to government healthcare agencies. The contract includes the supply of...
- This $67,003.20 firm-fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Haemonetics Corporation, a leading provider of blood and plasma management products and services. The contract does not have a set-aside designation. The award is for the delivery of 0236-00 items as described in the contract, likely blood processing equipment and consumables. Haemonetics is an established medical device manufacturer that has received...
- The Defense Health Agency awarded a $81,976 purchase order to Haemonetics Corporation on August 12, 2025, for the procurement of a Haemonetics Bloodtrack Refrigerator, with completion targeted for September 30, 2025. This firm fixed-price contract was awarded on a full and open competitive basis with no set-aside designation. Haemonetics Corporation, a leading medical technology company headquartered in Boston, Massachusetts, specializes in blood and plasma management products and has been...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading provider of blood and plasma supplies and services, for $30,688.30. The contract is for blood consumable supplies such as blood bags, tubing sets, reagents, and solutions. The award has an ultimate completion date of August 1, 2022 and does not utilize a set-aside. Haemonetics is the prime contractor and no subcontractors are identified. The DHA, which delivers integrated...
- This is a $17,070,912.72 Firm Fixed Price Delivery Order awarded by the Defense Health Agency to 5D Information Management, Inc., a subsidiary of Haemonetics Corporation. The contract is for the provision of labor and has a completion date of December 19, 2023. The contract does not have a set-aside designation. Haemonetics is a provider of blood and plasma supplies and services, including devices and consumables for blood collection, processing, and management. The company has a history of...
- The Defense Health Agency, a component of the Department of Defense, awarded a $24,028 purchase order to Haemonetics Corporation for the delivery of 325ml of DE-GLYCE. Performance will take place in Bethesda, Maryland under firm fixed pricing. As a leading provider of blood and plasma collection, processing and delivery technologies, Haemonetics will supply the contracted medical device and consumables to support the Agency's health care programs. No subcontractors or set aside designations were...
- The federal contract HT001416P0025 was awarded to Haemonetics Corporation, a leading provider of blood and plasma management products and services to the U.S. government. The $14,700.00 firm-fixed price purchase order, issued by the Defense Health Agency, is for the maintenance and service of ACP (automated cell processors). The contract has no set-aside designation. The contract award is associated with a larger indefinite delivery vehicle (IDV) Haemonetics holds with the Department of Veterans...
- This is a $1,022.50 firm fixed-price purchase order awarded by the Defense Health Agency to Haemonetics Corporation, a leading medical technology company, for a post-thaw solution. The contract has no set-aside designation, indicating it was awarded on a full and open competitive basis. Haemonetics Corporation also holds a larger $3,824,433.60 Indefinite Delivery Contract with the Department of Veterans Affairs for procuring autotransfusion units and related medical equipment to support surgical...
The Defense Health Agency awarded a firm fixed-price purchase order valued at $33,511.85 to Haemonetics Corporation for annual maintenance services on BloodTrack V5 kiosk and EMERGE equipment. The contract, awarded on November 10, 2025, will be performed at Portsmouth Naval Medical Center in Portsmouth, Virginia, with an ultimate completion date of November 9, 2030. This award represents a continuation of Haemonetics' established relationship with the Defense Health Agency as a primary supplier of blood and plasma management solutions and related support services to the Department of Defense healthcare system. Haemonetics Corporation, headquartered in Boston, Massachusetts, is a leading medical technology company specializing in blood management equipment and clinical support services for federal healthcare agencies. The company has maintained an extensive federal contract portfolio since 2002, providing hemostasis analyzers, autotransfusion units, blood recovery systems, and comprehensive maintenance support to military medical facilities and VA medical centers nationwide. This purchase order was awarded without set-aside designation on a competitive basis, reflecting Haemonetics' established position as a qualified supplier capable of competing in open federal procurement. The contract includes no identified subcontractors, with Haemonetics serving as the prime contractor responsible for all maintenance obligations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 11/4/25 |